- Report
- February 2026
- 375 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 227 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 390 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 294 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 401 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 461 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 282 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 383 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 291 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 217 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 275 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 170 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 475 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 242 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 221 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 178 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 174 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 178 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 475 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 459 Pages
Global
From €5124EUR$5,850USD£4,447GBP

Gene Editing is a technology used in genomics to modify the genetic material of living organisms. It is used to make changes to the DNA sequence of a gene, such as deleting, inserting, or replacing a gene. This technology has been used to create genetically modified organisms, which have been used in research and medical applications. It has also been used to create gene therapies, which are treatments that use gene editing to modify a patient's genetic material to treat a disease.
Gene Editing is a rapidly growing market, with many companies developing new technologies and applications. Companies such as Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, and Sangamo Therapeutics are leading the way in developing gene editing technologies and treatments. Other companies such as Cellectis, Caribou Biosciences, and Twist Bioscience are also developing gene editing technologies and products. Show Less Read more